Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for pulmonary function and quality of life in obese COPD patients
2017-003551-32Phase 4Completed
- Sponsor
- Hospital of South West Jutland
- Start
- Nov 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of liraglutide in chronic obstructive pulmonary disease (COPD) and obesity, sponsored by Hospital of South West Jutland. Primary endpoint: Transition Dyspnea Index (TDI) at 40 weeks. Started Nov 2017; status: completed.
02
Drugs
03
Conditions
chronic obstructive pulmonary disease (COPD)obesity
Beyond the preview
Go deeper on 2017-003551-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003551-32.